Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H22N2O2.C4H6O6 |
Molecular Weight | 400.4235 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
InChI
InChIKey=GWHQHAUAXRMMOT-MBANBULQSA-N
InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1
Molecular Formula | C14H22N2O2 |
Molecular Weight | 250.3367 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C4H6O6 |
Molecular Weight | 150.0868 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:30:29 UTC 2023
by
admin
on
Fri Dec 15 15:30:29 UTC 2023
|
Record UNII |
9IY2357JPE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE ACTAVIS (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
||
|
NCI_THESAURUS |
C47792
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE ACTAVIS (AUTHORIZED: DEMENTIA)
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIVASTIGMINE ACTAVIS (AUTHORIZED: ALZHEIMER DISEASE)
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6918078
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
DBSALT001252
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
9IY2357JPE
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
1604858
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
129101-54-8
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
9IY2357JPE
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
CHEMBL636
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
m9639
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB04257MIG
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
100000093043
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
DTXSID8047840
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
994808
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | RxNorm | ||
|
C47707
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
64358
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY | |||
|
Rivastigmine tartrate
Created by
admin on Fri Dec 15 15:30:29 UTC 2023 , Edited by admin on Fri Dec 15 15:30:29 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |